Background
==========

In the recently halted human immunodeficiency virus type 1 (HIV-1) vaccine STEP trial individuals that were seropositive for adenovirus serotype 5 (Ad5) showed increased rates of HIV-1 infection on vaccination with an Ad5 vaccine. We undertook a series of *ex vivo*strategies to address the hypothesis that immunisation of Ad5 seropositive individuals with adenoviral vectors may result in activation, expansion, and trafficking of Ad5-specific memory CD4 T cells to mucosal tissues thereby increasing the number of HIV-1 susceptible targets at the initial sites of infection.

Methods
=======

Ad5 and Ad11 antibody titers were measured in 20 healthy volunteers. Dendritic cells (DC) were generated from these individuals, pulsed with replication defective Ad5 or Ad11 and co-cultured with autologous lymphocytes. Cytokine profiles, proliferative capacity and the migration potential of the adenovirus-stimulated memory T cells were measured. The susceptibility of re-stimulated memory Ad-specific T cells to infection with a CCR5-utilising HIV-1 was also assessed by multi-colour flow cytometric analysis and p24 ELISA assays.

Results
=======

Stimulation of T cells from Ad5 seropositive but Ad11 seronegative individuals with Ad5, or serologically distinct Ad11 vectors induced expansion of adenovirus memory CD4 T cells expressing alpha 4 beta 7 and CCR9, indicating a mucosal-homing phenotype. CD4 T cell proliferation and IFN-gamma production in response to Ad stimulation correlated with Ad5 antibody titers. In contrast, Ad5 serostatus did not correlate with total cytokine production upon re-challenge with Ad5 or Ad11. Expanded Ad5 and Ad11 memory CD4 T cells showed an increase in CCR5 expression and higher susceptibility to infection by R5 tropic HIV-1.

Conclusion
==========

Adenoviral-based vaccination against HIV-1 in individuals with pre-existing immunity against Ad5 may result in preferential expansion of HIV-susceptible activated CD4 T cells that home to mucosal tissues, increase the number of virus targets and lead to a higher susceptibility to HIV infection.
